Top Funds / PERCEPTIVE ADVISORS LLC


Joseph Edelman

2020Q4 Portfolio

SEC 13F Filing

Position #Shares $Value % # vs. 2020Q3 $ vs. 2020Q3
Mirati Therapeutics, Inc. 3,693,516 $811,244,000 8.71% +257,941 +$240,767,000
AMICUS THERAPEUTICS, INC. 25,112,048 $579,837,000 6.22% -10,000 +$225,114,000
BridgeBio Pharma, Inc. 6,706,268 $476,883,000 5.12% No Change +$225,264,000
Retrophin, Inc. NOTE 2.500% 9/1 45,000,000 $442,521,000 4.75% No Change +$52,402,000
IOVANCE BIOTHERAPEUTICS, INC. 9,166,304 $425,316,000 4.56% -919,328 +$93,297,000
Invitae Corp 7,284,466 $304,563,000 3.27% New +$304,563,000
SpringWorks Therapeutics, Inc. 4,177,721 $302,968,000 3.25% +696,573 +$137,022,000
Global Blood Therapeutics, Inc. 5,674,711 $245,771,000 2.64% -126,285 -$74,096,000
Horizon Therapeutics Public Ltd Co 3,084,042 $225,597,000 2.42% New +$225,597,000
Zymeworks Inc. 4,300,999 $203,265,000 2.18% -100,000 -$1,734,000
ROCKET PHARMACEUTICALS, INC. 3,396,867 $186,284,000 2.00% +1,207,857 +$136,243,000
NEUROCRINE BIOSCIENCES INC 1,899,215 $182,040,000 1.95% +350,500 +$33,116,000
COLLEGIUM PHARMACEUTICAL, INC NOTE 2.625% 2/1 17,500,000 $173,250,000 1.86% No Change +$9,485,000
NEVRO CORP 977,565 $169,217,000 1.82% +151,401 +$54,132,000
NEVRO CORP NOTE 2.750% 4/0 9,000,000 $165,420,000 1.78% No Change +$23,598,000
OUTSET MED INC 2,847,822 $161,870,000 1.74% No Change +$19,479,000
VBI Vaccines Inc/BC 55,042,465 $151,366,000 1.62% No Change -$6,055,000
Athenex, Inc. 13,532,467 $149,669,000 1.61% No Change -$11,654,000
ATEA PHARMACEUTICALS INC 3,109,224 $129,903,000 1.39% New +$129,903,000
NOVAVAX INC 1,043,000 $116,305,000 1.25% +335,285 +$39,624,000
Frequency Therapeutics, Inc. 3,259,635 $114,935,000 1.23% +3,117 +$52,377,000
Kodiak Sciences Inc. 751,533 $110,408,000 1.18% -291,488 +$48,651,000
ATHIRA PHARMA INC 3,114,805 $106,682,000 1.14% No Change +$49,183,000
MeiraGTx Holdings plc 6,933,277 $104,970,000 1.13% +500,000 +$19,794,000
C4 THERAPEUTICS INC STK 3,158,566 $104,643,000 1.12% New +$104,643,000